SYNDAX PHARMACEUTICALS INC
SNDX · NASDAQ
Updated at 2026-10-13 14:35:20
- Today's High
- $14.75
- Today’s Low
- $13.49
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $16.88
- Previous Close
- $16.55
- Volume
- 2.03M
- Market Cap
- $1.47B
- P/E Ratio
- --
- EPS
- $-2.52
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 730 THIRD AVENUE, NEW YORK, NY, UNITED STATES, 10017
- Country
- US
- Listing Date
- 2016-03-03
- Fiscal Year End
- December
- Shares Outstanding
- 88.61M
- CIK
- 0001395937
- Website
- syndax.com
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company is headquartered in Waltham, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$72.78M
2026-03-31
$64.86M
2025-12-31
$68.48M
2025-09-30
$45.87M
Operating Expenses
2026-06-30
$109.57M
2026-03-31
$96.43M
2025-12-31
$132.6M
2025-09-30
$101.19M
Net Income
2026-06-30
-$49.36M
2026-03-31
-$42.67M
2025-12-31
-$68.01M
2025-09-30
-$60.71M
Net Profit Margin
2026-06-30
-67.81%
2026-03-31
-65.78%
2025-12-31
-99.31%
2025-09-30
-132.36%
Earnings Per Share
2026-06-30
$-0.55
2026-03-31
$-0.48
2025-12-31
$-0.78
2025-09-30
$-0.70
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$36.68M
2026-03-31
-$30.82M
2025-12-31
-$15.3M
2025-09-30
-$52.42M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $72.78M | $64.86M | $68.48M | $45.87M |
| Operating Expenses | $109.57M | $96.43M | $132.6M | $101.19M |
| Net Income | -$49.36M | -$42.67M | -$68.01M | -$60.71M |
| Net Profit Margin | -67.81% | -65.78% | -99.31% | -132.36% |
| Earnings Per Share | $-0.55 | $-0.48 | $-0.78 | $-0.70 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$36.68M | -$30.82M | -$15.3M | -$52.42M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.